Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
上海药明康德新药开发有限公司 SHANGHAI PHARMATECHS CO.LTD
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
WuXi STA and Antengene Sign Development and Manufacturing Agreement
2018-07-20 08:00
WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange
2018-05-08 11:44
WuXi STA Changzhou Site Passes First U.S. FDA Inspection
2018-05-07 08:00
WuXi STA Announces to Build a New R&D Center in Shanghai
2018-04-27 08:00
WuXi AppTec Expands Site in the U.S. for Drug Development Testing Services
2018-04-19 11:54
WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration
2018-02-22 15:23
WuXi AppTec Launches Advanced Library Compound Initiative on LabNetwork.com
2018-02-06 21:00
WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing Collaboration Following Successful IND Filing for AVB-S6-500
2018-01-30 09:00
WuXi Biologics Announces Formation of Scientific Advisory Board
2018-01-24 17:05
WuXi Biologics Appoints Dr. Chiang Syin, a Former FDA Officer as Chief Quality Officer
2018-01-15 08:10
WuXi Biologics and Phanes Sign MOU and Announce Strategic Development and Manufacturing Partnership
2017-12-14 17:20
WuXi Biologics Initiated cGMP Manufacturing in the World's Largest Biologics Manufacturing Facility Using Only Single-Use Bioreactors
2017-12-06 16:23
WuXi Biologics and Pall Corporation Establish Joint Continuous Bioprocess Laboratory
2017-11-03 10:30
WuXi AppTec Acquires ResearchPoint Global to Better Enable Clinical Development Worldwide
2017-10-18 05:30
WuXi AppTec Receives 2017 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan
2017-10-09 08:00
WuXi Biologics Announces 2017 Interim Results
2017-08-22 14:03
WuXi Biologics and Gloria Pharmaceuticals Announce the Licensure of the Fully Human PD-1 Antibody, GLS-010, to Arcus Biosciences
2017-08-17 19:22
WuXi's Pharmaceutical Development Services Division Merges with STA
2017-07-31 08:00
STA Signs Supply Agreement with TESARO
2017-07-24 08:00
WuXi Biologics is Officially Listed on the Hong Kong Stock Exchange
2017-06-13 09:55
1
2
3
4
5
6
19